Comparison Chart Valneva SE

Stocks

VLA

FR0004056851

Biotechnology & Medical Research

Real-time Euronext Paris 06:38:59 2026-08-18 EDT			5-day change	1st Jan Change
2.920 ^EUR	-4.95%		+17.50%	-21.62%

08-14	Pfizer and Valneva Se Announce European Medicines Agency Validation of Marketing Authorization Application for Lyme Disease Vaccine Candidate	CI
08-14	Pfizer Inc. and Valneva Se Enter Strategic Alliance for Co-Development of Lyme Disease Vaccine Candidate	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	VALNEVA SE	Other Biotechnology & Medical Research	-4.95%	+17.50%	-21.62%	-42.47%	-75.51%	675M